TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bionordika AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,771
|
38,225
|
50,692 |
Financial expenses |
517
|
487
|
538 |
Earnings before taxes |
2,363
|
7,807
|
14,543 |
Total assets |
12,094
|
18,834
|
27,142 |
Current assets |
11,642
|
18,510
|
26,870 |
Current liabilities |
7,129
|
13,325
|
21,549 |
Equity capital |
4,885
|
5,372
|
5,592 |
- share capital |
68
|
72
|
76 |
Employees (average) | 10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
40.4%
|
28.5%
|
20.6% |
Turnover per employee | 5,069 | ||
Profit as a percentage of turnover |
7.9%
|
20.4%
|
28.7% |
Return on assets (ROA) |
23.8%
|
44.0%
|
55.6% |
Current ratio |
163.3%
|
138.9%
|
124.7% |
Return on equity (ROE) |
48.4%
|
145.3%
|
260.1% |
Change turnover |
-6,105
|
-9,805
|
-4,570 |
Change turnover % |
-17%
|
-20%
|
-8% |
Chg. No. of employees | -3 | ||
Chg. No. of employees % | -23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.